Eltrombopag 25 mg/1

Eltrombopag 25 mg/1 is a powder for oral suspension used to support platelet production. This medication is commonly prescribed for conditions affecting blood cell counts. Eltrombopag olamine helps manage low platelet levels in the blood.

Eltrombopag 25 mg/1 is primarily used to increase platelet counts in individuals with certain medical conditions. It is often prescribed for conditions where the body does not produce enough platelets, such as chronic immune thrombocytopenia. This medication works by stimulating the production of platelets in the bone marrow, helping to maintain healthy blood cell levels.

Common effects of Eltrombopag 25 mg/1 may include increased platelet counts, which can help reduce the risk of bleeding. Some individuals may experience mild gastrointestinal discomfort or changes in liver function. It is important to monitor blood cell counts regularly while using this medication.

Eltrombopag 25 mg/1 should be used under medical supervision. It is important to follow the prescribed dosage and administration instructions. Individuals with liver conditions should use this medication with caution. Regular blood tests may be required to monitor the effects of the medication.

Eltrombopag 25 mg/1 may interact with certain medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Avoid consuming alcohol while using this medication, as it may increase the risk of side effects.